# Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

> **NCT07038941** · PHASE1 · COMPLETED · sponsor: **Beijing Dayspring Pharmaceutical Technology Co., Ltd** · enrollment: 44 (actual)

## Conditions studied

- Male Pattern of Hair Loss, Androgenic Alopecia
- Androgenetic Alopecia (AGA)

## Interventions

- **DRUG:** CG2001
- **DRUG:** Placebo foam

## Key facts

- **NCT ID:** NCT07038941
- **Lead sponsor:** Beijing Dayspring Pharmaceutical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-19
- **Primary completion:** 2024-06-02
- **Final completion:** 2024-06-02
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038941, "Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07038941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*